This written thesis examines the process of producing Herb and Life: a Chinese Medical Family, a thirty-minute documentary video that explores the producer's family members' relationship with Traditional Chinese Medicine. This documentary uses interviews, narration, music, and observational sequences to display documentary subjects' career choices and their experiences with Traditional Chinese Medicine. This written thesis reveals the development of this documentary, from the pre-production to production and post-production stages. It also incorporates theoretical analysis and self-evaluation of this documentary video.

by Fung Yin Lee, Annie. / Thesis (M.Phil.)--Chinese University of Hong Kong, 1995. / Includes bibliographical references (leaves 181-189). / ABSTRACT --- p.i / LIST OF ABBREVIATIONS --- p.iv / ACKNOWLEDGEMENT --- p.v / TABLE OF CONTENTS --- p.vi / LIST OF FIGURES --- p.ix / INTRODUCTION --- p.1 / LITERATURE REVIEW --- p.4 / Chapter I. --- A. Arterial pressure --- p.4 / Chapter B. --- Regulation of arterial pressure --- p.7 / Chapter II. --- Hypertension --- p.14 / Chapter III. --- Treatment of hypertension --- p.29 / Chapter IV. --- Plants and their effects on blood pressure --- p.48 / Chapter V. --- Characteristics of the three plants being studied --- p.50 / MATERIALS AND METHODS --- p.55 / Chapter A. --- Preparative procedures --- p.55 / Chapter 1. --- Preparation of plant extracts --- p.55 / Chapter 2. --- Animal preparation for invivo blood pressure measurement --- p.56 / Chapter 3. --- Preparation of right atria for in vitro studies --- p.56 / Chapter 4. --- Preparation of artery strips for in vitro studies --- p.57 / Chapter 5. --- Preparation for diuretic studies --- p.58 / Chapter B. --- Experiments done --- p.60 / Chapter 1. --- Cumulative dose response of individual plant extract --- p.60 / Chapter 2. --- Combination of plant extracts --- p.60 / Chapter 3. --- Pharmacological antagonists studies --- p.64 / Chapter a. --- Autonomic ganglion transmission --- p.64 / Chapter b. --- Alpha adrenergic activity --- p.64 / Chapter c. --- Beta adrenergic activity --- p.65 / Chapter d. --- Cholinergic activity --- p.65 / Chapter e. --- Histaminergic activity --- p.65 / Chapter f. --- Serotoninergic activity --- p.65 / Chapter 4. --- Urinary and sodium excretionin water loaded rats --- p.66 / Chapter 5. --- Studies on chronotropic and inotropic effects on isolated right atrium --- p.66 / Chapter a. --- Effect of individual plant extract --- p.66 / Chapter b. --- Effect of combination of plant extracts --- p.66 / Chapter 6. --- Effect of plant extract on contractile responses of rat tail artery strips --- p.70 / Chapter a. --- Effect of individual plant extract --- p.70 / Chapter b. --- Effect of combination of plant extracts --- p.70 / Chapter 7. --- Effect of acute oral feeding of plant extracts on blood pressure of rats --- p.71 / Chapter C. --- Statistics --- p.71 / RESULTS / Chapter A. --- Preparation of plant extracts --- p.72 / Chapter B. --- Effect of plant extracts on blood pressure changes --- p.72 / Chapter 1. --- Individual plant extract --- p.72 / Chapter 2. --- Combination of two plant extracts --- p.73 / Chapter 3. --- Combination of three plant extracts --- p.76 / Chapter C. --- Pharmacological antagonist studies --- p.79 / Chapter 1. --- Autonomic ganglion transmission --- p.79 / Chapter 2. --- Alpha adrenergic activity --- p.79 / Chapter 3. --- Beta adrenergic activity --- p.81 / Chapter 4. --- Cholinergic activity --- p.82 / Chapter 5. --- Histaminergic activity --- p.83 / Chapter 6. --- Serotoninergic activity --- p.84 / Chapter D. --- Urinary and sodium excretion in water loaded rats --- p.85 / Chapter E. --- Chronotropic and inotropic studies of isolated right atrium --- p.88 / Chapter 1. --- Effect of individual plant extract --- p.88 / Chapter 2. --- Effect of combination of plant extracts --- p.89 / Chapter F. --- Effect of plant extracts on contractile responses of rat tail artery strips --- p.101 / Chapter G. --- Effect of acute oral feeding of plant extracts on MAP of rats --- p.102 / DISCUSSION --- p.156 / Chapter A. --- Comment on preparation of plant extracts --- p.156 / Chapter B. --- The hypotensive effects of the plant extracts --- p.157 / Chapter C. --- The mechanism of action --- p.159 / Chapter D. --- The renal effect of plant extracts --- p.161 / Chapter E. --- The interaction of the hypotensive effect of plant extracts --- p.164 / Chapter F. --- In vitro studies --- p.167 / Chapter G. --- The oral effect of the plant extracts --- p.174 / SUMMARY --- p.176 / CONCLUSION --- p.179 / REFERENCES --- p.181 / APPENDIX --- p.190 / "Appendix I To study the hypotensive effects of trypsin treated green bean, rue and kelp" --- p.191 / "Appendix II To study the hypotensive effects of ether treated green bean, rue and kelp" --- p.194

by Leung Chi Hong. / Thesis (M.Phil.)--Chinese University of Hong Kong, 1992. / Includes bibliographical references (leaves 183-184). / Chapter Chapter one: --- Introduction --- p.1 / Chapter Chapter two: --- Background knowledge and linguistic approaches of automatic indexing --- p.5 / Chapter 2.1 --- Definition of index and indexing --- p.5 / Chapter 2.2 --- Indexing methods and problems --- p.7 / Chapter 2.3 --- Automatic indexing and human indexing --- p.8 / Chapter 2.4 --- Different approaches of automatic indexing --- p.10 / Chapter 2.5 --- Example of semantic approach --- p.11 / Chapter 2.6 --- Example of syntactic approach --- p.14 / Chapter 2.7 --- Comments on semantic and syntactic approaches --- p.18 / Chapter Chapter three: --- Rationale and methodology of automatic index generation --- p.19 / Chapter 3.1 --- Problems caused by natural language --- p.19 / Chapter 3.2 --- Usage of word frequencies --- p.20 / Chapter 3.3 --- Brief description of rationale --- p.24 / Chapter 3.4 --- Automatic index generation --- p.27 / Chapter 3.4.1 --- Training phase --- p.27 / Chapter 3.4.1.1 --- Selection of training documents --- p.28 / Chapter 3.4.1.2 --- Control and standardization of variants of words --- p.28 / Chapter 3.4.1.3 --- Calculation of associations between words and indexes --- p.30 / Chapter 3.4.1.4 --- Discarding false associations --- p.33 / Chapter 3.4.2 --- Indexing phase --- p.38 / Chapter 3.4.3 --- Example of automatic indexing --- p.41 / Chapter 3.5 --- Related researches --- p.44 / Chapter 3.6 --- Word diversity and its effect on automatic indexing --- p.46 / Chapter 3.7 --- Factors affecting performance of automatic indexing --- p.60 / Chapter 3.8 --- Application of semantic representation --- p.61 / Chapter 3.8.1 --- Problem of natural language --- p.61 / Chapter 3.8.2 --- Use of concept headings --- p.62 / Chapter 3.8.3 --- Example of using concept headings in automatic indexing --- p.65 / Chapter 3.8.4 --- Advantages of concept headings --- p.68 / Chapter 3.8.5 --- Disadvantages of concept headings --- p.69 / Chapter 3.9 --- Correctness prediction for proposed indexes --- p.78 / Chapter 3.9.1 --- Example of using index proposing rate --- p.80 / Chapter 3.10 --- Effect of subject matter on automatic indexing --- p.83 / Chapter 3.11 --- Comparison with other indexing methods --- p.85 / Chapter 3.12 --- Proposal for applying Chinese medical knowledge --- p.90 / Chapter Chapter four: --- Simulations of automatic index generation --- p.93 / Chapter 4.1 --- Training phase simulations --- p.93 / Chapter 4.1.1 --- Simulation of association calculation (word diversity uncontrolled) --- p.94 / Chapter 4.1.2 --- Simulation of association calculation (word diversity controlled) --- p.102 / Chapter 4.1.3 --- Simulation of discarding false associations --- p.107 / Chapter 4.2 --- Indexing phase simulation --- p.115 / Chapter 4.3 --- Simulation of using concept headings --- p.120 / Chapter 4.4 --- Simulation for testing performance of predicting index correctness --- p.125 / Chapter 4.5 --- Summary --- p.128 / Chapter Chapter five: --- Real case study in database of Chinese Medicinal Material Research Center --- p.130 / Chapter 5.1 --- Selection of real documents --- p.130 / Chapter 5.2 --- Case study one: Overall performance using real data --- p.132 / Chapter 5.2.1 --- Sample results of automatic indexing for real documents --- p.138 / Chapter 5.3 --- Case study two: Using multi-word terms --- p.148 / Chapter 5.4 --- Case study three: Using concept headings --- p.152 / Chapter 5.5 --- Case study four: Prediction of proposed index correctness --- p.156 / Chapter 5.6 --- Case study five: Use of (Σ ΔRij) Fi to determine false association --- p.159 / Chapter 5.7 --- Case study six: Effect of word diversity --- p.162 / Chapter 5.8 --- Summary --- p.166 / Chapter Chapter six: --- Conclusion --- p.168 / Appendix A: List of stopwords --- p.173 / Appendix B: Index terms used in case studies --- p.174 / References --- p.183

by Lau Tai Wai. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2000. / Includes bibliographical references (leaves 117-127). / Abstracts in English and Chinese. / Table of Content --- p.i / Abbreviations --- p.iv / Abstract --- p.v / List of Figures --- p.ix / List of Tables --- p.xii / Chapter 1. --- Chapter One: Introduction --- p.1 / Chapter 1.1 --- Background on orchids --- p.2 / Chapter 1.2 --- Background on Dendrobium --- p.7 / Chapter 1.3 --- Background and history on Herba Dendrobii --- p.9 / Chapter 1.4 --- Reasons for study of Herba Dendrobii --- p.12 / Chapter 1.4.1 --- Demand --- p.12 / Chapter 1.4.2 --- Adulteration --- p.13 / Chapter 1.4.3 --- CITES --- p.13 / Chapter 1.5 --- Scientific researches on Herba Dendrobii --- p.14 / Chapter 1.5.1 --- Morphological studies --- p.15 / Chapter 1.5.2 --- Anatomical and microscopic studies --- p.16 / Chapter 1.5.3 --- Phytochemistry --- p.20 / Chapter 1.5.3.1 --- Chemicals identified --- p.20 / Chapter 1.5.3.2 --- Chemical authentication of Herba Dendrobii --- p.23 / Chapter 1.5.3.3 --- Effect of treatment on chemical composition --- p.23 / Chapter 1.5.4 --- Phylogenetic study of Dendrobium --- p.25 / Chapter 1.5.4.1 --- Phylogenetic analysis by molecular methods --- p.25 / Chapter 1.5.4.2 --- Phylogenetic analysis by anatomical methods --- p.27 / Chapter 1.5.5 --- Pharmacological effect --- p.29 / Chapter 2. --- Chapter two: Objectives and strategies --- p.30 / Chapter 3. --- Chapter Three: Materials and Methods --- p.33 / Chapter 3.1 --- Source of samples and their treatment --- p.34 / Chapter 3.1.1 --- Fresh materials --- p.34 / Chapter 3.1.2 --- Dry materials --- p.34 / Chapter 3.1.3 --- Outgroup species --- p.35 / Chapter 3.2 --- Experimental protocol --- p.40 / Chapter 3.2.1 --- Rationale of the experiment --- p.40 / Chapter 3.2.2 --- DNA extraction --- p.41 / Chapter 3.2.2.1 --- Cetyltrimethylammonium bromide extraction method --- p.41 / Chapter 3.2.2.1a --- Reagents and buffers --- p.41 / Chapter 3.2.2.1b --- Procedures of CTAB extraction method --- p.42 / Chapter 3.2.2.2 --- Modified DNA isolation protocol for dry samples --- p.43 / Chapter 3.2.2.2a --- Reagents and buffers --- p.43 / Chapter 3.2.2.2b --- Procedures of modified DNA isolation protocol for dry plant samples --- p.44 / Chapter 3.2.3 --- Agarose gel electrophoresis of genomic DNA or PCR products --- p.45 / Chapter 3.2.3a --- Reagents and buffers --- p.45 / Chapter 3.2.3b --- Procedures of agarose gel electrophoresis of genomic DNA or PCR products --- p.45 / Chapter 3.2.4 --- Qualitative and quantitative analysis of DNA --- p.46 / Chapter 3.2.5 --- Amplification of the internal transcribed spacer 2 (ITS 2) region by Polymerase Chain Reaction --- p.47 / Chapter 3.2.5a --- Internal transcribed spacer 2 (ITS 2) region --- p.47 / Chapter 3.2.5b --- Procedures of polymerase chain reaction of ITS 2 region --- p.48 / Chapter 3.2.6 --- Purification of PCR products or cycle sequencing products --- p.48 / Chapter 3.2.6.1 --- Ethanol precipitation --- p.48 / Chapter 3.2.6.2 --- GENECLEAN® protocols --- p.49 / Chapter 3.2.6.3 --- Spin Column Purification --- p.49 / Chapter 3.2.7 --- Cycle Sequencing --- p.50 / Chapter 3.2.8 --- Sample Electrophoresis --- p.51 / Chapter 3.2.8a --- Equipment and reagents --- p.51 / Chapter 3.2.8b --- Procedures of sample electrophoresis --- p.52 / Chapter 3.2.9 --- Sequence analysis --- p.52 / Chapter 4. --- Results --- p.53 / Chapter 4.1 --- Fresh materials --- p.54 / Chapter 4.1.1 --- Genomic DNA --- p.54 / Chapter 4.1.2 --- PCR products --- p.59 / Chapter 4.1.3 --- Sequence alignment --- p.66 / Chapter 4.1.4 --- Comparison of the sequences --- p.94 / Chapter 4.1.5 --- Percentage difference among Dendrobium --- p.96 / Chapter 4.1.6 --- Intra-specific variation of orchid species --- p.96 / Chapter 4.1.7 --- Phylogenetic analysis --- p.99 / Chapter 4.2 --- Dry materials --- p.101 / Chapter 4.2.1 --- Genomic DNA --- p.101 / Chapter 4.2.2 --- PCR products --- p.101 / Chapter 4.2.3 --- Sequencing result --- p.101 / Chapter 5. --- Discussion and Conclusion --- p.107 / Chapter 5.1 --- Reasons for authentication of Herba Dendrobii --- p.108 / Chapter 5.2 --- Fresh materials of Herba Dendrobii --- p.109 / Chapter 5.2.1 --- Authentication --- p.109 / Chapter 5.2.2 --- Phylogenetic analysis --- p.111 / Chapter 5.3 --- Dry materials of Herba Dendrobii --- p.114 / Chapter 5.4 --- Evaluation of the experimental method --- p.115 / Chapter 5.5 --- Conclusion --- p.116 / Chapter 6. --- Reference --- p.117 / Chapter 7. --- Appendix / Appendix 1: Number of species in each medicinal orchid geneus --- p.128 / Appendix 2: Photographs showing 15 of the 17 species of orchids used in this research project --- p.131

by Yau Ming Hon. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2002. / Includes bibliographical references (leaves 131-154). / Abstracts in English and Chinese. / Contents --- p.i / Acknowledgements --- p.ix / Abstract --- p.x / 槪論 --- p.xi / List of abbreviations --- p.xii / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Reactive oxygen species (ROS) --- p.2 / Chapter 1.1.1 --- Hydrogen peroxide --- p.2 / Chapter 1.1.2 --- Superoxide anion --- p.3 / Chapter 1.1.3 --- Hydroxyl radical --- p.3 / Chapter 1.1.4 --- Carbon centered radical --- p.4 / Chapter 1.1.5 --- Nitric oxide --- p.4 / Chapter 1.2 --- Physiological roles of ROS --- p.5 / Chapter 1.2.1 --- Signal transduction --- p.5 / Chapter 1.2.2 --- Phagocytic activity --- p.6 / Chapter 1.3 --- Defense systems against ROS --- p.7 / Chapter 1.3.1 --- Endogenous antioxidant enzymes --- p.8 / Chapter 1.3.1.1 --- Catalase --- p.8 / Chapter 1.3.1.2 --- Superoxide dismutase --- p.8 / Chapter 1.3.1.3 --- Selenium-glutathione peroxidase --- p.9 / Chapter 1.3.1.4 --- Glutathione reductase --- p.10 / Chapter 1.3.1.5 --- Glutathione-S-transferases --- p.10 / Chapter 1.3.2 --- Non-enzymatic antioxidants --- p.12 / Chapter 1.3.2.1 --- Vitamin E (tocopherols and tocotrienols) --- p.12 / Chapter 1.3.2.2 --- Vitamin C (L-ascorbic acid) --- p.13 / Chapter 1.3.2.3 --- Glutathione --- p.14 / Chapter 1.3.2.4 --- Flavonoids and polyphenols --- p.15 / Chapter 1.3.2.5 --- Uric acid --- p.16 / Chapter 1.4 --- Roles of ROS in pathogenesis --- p.16 / Chapter 1.4.1 --- Liver diseases --- p.17 / Chapter 1.4.2 --- Genital malfunctioning --- p.19 / Chapter 1.5 --- "The traditional Chinese medicinal formula, Wu-zi-yan-zong-wan" --- p.19 / Chapter 1.5.1 --- Pharmacology of individual herbal components --- p.20 / Chapter 1.5.1.1 --- Semen Cuscuta --- p.20 / Chapter 1.5.1.2 --- Fructus Lycii --- p.21 / Chapter 1.5.1.3 --- Fructus Schisandrae --- p.21 / Chapter 1.5.1.4 --- Fructus Rubi --- p.22 / Chapter 1.5.1.5 --- Semen Plantaginis --- p.22 / Chapter 1.5.2 --- Effect of Wu-zi-yan-zong-wan on infertility --- p.23 / Chapter 1.5.3 --- Effect of Wu-zi-yan-zong-wan on liver disease --- p.23 / Chapter 1.6 --- Objectives of the present study --- p.24 / Chapter Chapter 2 --- Antioxidant Activity of Aqueous Extracts of the Herbal Components of Wu-zi-yan-zong-wan in in vitro Free Radical Generating Systems --- p.26 / Chapter 2.1 --- Introduction --- p.27 / Chapter 2.1.1 --- Application of in vitro ROS generating systems --- p.27 / Chapter 2.1.1.1 --- Superoxide generation --- p.27 / Chapter 2.1.1.2 --- Hydroxyl radical generation system --- p.28 / Chapter 2.1.1.3 --- "2,2'-Azobis(2-amidinopropane) dihydrochloride- induced hemolysis" --- p.28 / Chapter 2.1.1.4 --- Bleomycin-iron-dependent DNA damage --- p.28 / Chapter 2.1.2 --- Objective --- p.29 / Chapter 2.2 --- Materials and methods --- p.30 / Chapter 2.2.1 --- Materials --- p.30 / Chapter 2.2.2 --- Preparation of aqueous herbal extracts --- p.30 / Chapter 2.2.3 --- Superoxide-scavenging assay --- p.30 / Chapter 2.2.4 --- Microsome lipid peroxidation inhibition assay --- p.31 / Chapter 2.2.5 --- "2,2'-Azobis(2-amidinopropane) dihydrochloride-induced hemolysis inhibition assay" --- p.32 / Chapter 2.2.6 --- Bleomycin-iron-dependent DNA damage inhibition assay --- p.32 / Chapter 2.2.7 --- Statistical analysis --- p.33 / Chapter 2.3 --- Results --- p.34 / Chapter 2.3.1 --- Extraction yield --- p.34 / Chapter 2.3.2 --- Free radical scavenging activity of Wu-zi-yan-zong-wan extract --- p.34 / Chapter 2.3.3 --- Free radical scavenging activity of FR extract --- p.37 / Chapter 2.3.3.1 --- Superoxide-scavenging activity --- p.37 / Chapter 2.3.3.2 --- Effect on hydroxyl radical-induced lipid peroxidation --- p.37 / Chapter 2.3.3.3 --- Effect on AAPH-induced hemolysis --- p.40 / Chapter 2.3.3.4 --- Effect on bleomycin-iron-dependent DNA damage --- p.40 / Chapter 2.3.4 --- Pro-oxidant activity of FR extract --- p.40 / Chapter 2.3.5 --- Free radical scavenging activity of the remaining herbal extracts --- p.44 / Chapter 2.4 --- Discussion --- p.46 / Chapter Chapter 3 --- Effect of Aqueous Extract of the Herbal Components of Wu- zi-yan-zong-wan on tert-Butyl Hydroperoxide-Induced Oxidative Damage in Primary Rat Hepatocyte --- p.51 / Chapter 3.1 --- Introduction --- p.52 / Chapter 3.1.1 --- Primary rat hepatocyte as pharmacological model --- p.52 / Chapter 3.1.2 --- tert-Butyl hydroperoxide as an oxidative stress inducer --- p.53 / Chapter 3.1.3 --- Detection of ROS --- p.54 / Chapter 3.1.4 --- Objective --- p.55 / Chapter 3.2 --- Materials and methods --- p.56 / Chapter 3.2.1 --- Materials --- p.56 / Chapter 3.2.2 --- Primary rat hepatocyte isolation --- p.56 / Chapter 3.2.2.1 --- Liver perfusion --- p.56 / Chapter 3.2.2.2 --- Collagen pre-coated plates preparation --- p.57 / Chapter 3.2.2.3 --- Hepatocyte culture --- p.58 / Chapter 3.2.3 --- Drug treatment and oxidative stress induction --- p.58 / Chapter 3.2.4 --- Cytotoxicity assessment --- p.58 / Chapter 3.2.4.1 --- Lactate dehydrogenase leakage measurement --- p.59 / Chapter 3.2.4.2 --- MTT assay --- p.59 / Chapter 3.2.5 --- Cellular GSH content determination --- p.59 / Chapter 3.2.6 --- Protein determination by Lowry's method --- p.60 / Chapter 3.2.7 --- MDA measurement --- p.60 / Chapter 3.2.8 --- GSSG measurement --- p.61 / Chapter 3.2.9 --- ROS measurement with fluorescent dye --- p.61 / Chapter 3.2.10 --- "Vitamin C, vitamin E and butylated hydroxytoluene treatment" --- p.62 / Chapter 3.2.11 --- Antioxidant enzyme activity measurement --- p.62 / Chapter 3.2.11.1 --- Catalase activity measurement --- p.62 / Chapter 3.2.11.2 --- Superoxide dismutase activity measurement --- p.63 / Chapter 3.2.11.3 --- Glutathione peroxidase activity measurement --- p.63 / Chapter 3.2.11.4 --- Glutathione-S-transferases activity measurement --- p.63 / Chapter 3.2.11.5 --- Glutathione reductase activity measurement --- p.64 / Chapter 3.2.12 --- Statistical analysis --- p.64 / Chapter 3.3 --- Results --- p.65 / Chapter 3.3.1 --- Cytotoxicity of FR extract on rat hepatocyte --- p.65 / Chapter 3.3.2 --- Effect of tBHP and FR extract on hepatocyte viability --- p.65 / Chapter 3.3.3 --- Time-dependent effect of FR extract on tBHP-induced cytotoxicity --- p.69 / Chapter 3.3.4 --- Effect of tBHP and FR extract on hepatocyte GSH content --- p.69 / Chapter 3.3.5 --- Effect of tBHP and FR extract on GSSG formation in hepatocyte --- p.72 / Chapter 3.3.6 --- Effect of tBHP and FR extract on MDA formation in hepatocyte --- p.72 / Chapter 3.3.7 --- ROS-scavenging activity of FR extract in hepatocyte --- p.77 / Chapter 3.3.8 --- Effect of FR extract on antioxidant enzymes activities --- p.77 / Chapter 3.3.9 --- Comparison between typical antioxidants --- p.77 / Chapter 3.3.10 --- Effect of WZ and remaining herbal extracts on tBHP-induced oxidative damage in hepatocyte --- p.81 / Chapter 3.4 --- Discussion --- p.84 / Chapter Chapter 4 --- Effect of Aqueous Extract of Wu-zi-yan-zong-wan and Fructus Rubi on tert-Buty Hydroperoxide Induced Oxidative Damage in Mouse Model --- p.91 / Chapter 4.1 --- Introduction --- p.92 / Chapter 4.2 --- Materials and methods --- p.93 / Chapter 4.2.1 --- Materials --- p.93 / Chapter 4.2.2 --- Animal treatments --- p.93 / Chapter 4.2.3 --- Serum preparation --- p.94 / Chapter 4.2.4 --- Marker enzyme measurement --- p.94 / Chapter 4.2.5 --- Liver MDA and GSH determination --- p.95 / Chapter 4.2.6 --- Statistical analysis --- p.95 / Chapter 4.3 --- Results --- p.97 / Chapter 4.3.1 --- Effect of tBHP and FR extract on mouse serum ALT and AST activities --- p.97 / Chapter 4.3.2 --- Effect of tBHP and FR extract on mouse liver MDA and GSH content --- p.97 / Chapter 4.3.3 --- Effect of WZ extract on tBHP-induced increase in serum ALT and AST activities --- p.97 / Chapter 4.4 --- Discussion --- p.102 / Chapter Chapter 5 --- Characterization of the Active Antioxidant Principlein Aqueous Extract of FR --- p.105 / Chapter 5.1 --- Introduction --- p.106 / Chapter 5.2 --- Materials and methods --- p.107 / Chapter 5.2.1 --- Materials --- p.107 / Chapter 5.2.2 --- Chemical/physical treatments on FR extract --- p.107 / Chapter 5.2.3 --- Digestion with enzymes --- p.108 / Chapter 5.2.4 --- Antioxidant activity determination --- p.109 / Chapter 5.2.5 --- Chemical composition determination --- p.109 / Chapter 5.2.5.1 --- Uronic acid determination --- p.109 / Chapter 5.2.5.2 --- Hexose determination --- p.109 / Chapter 5.2.5.3 --- Tannin determination --- p.110 / Chapter 5.2.5.4 --- Protein determination --- p.110 / Chapter 5.2.6 --- Column chromatography --- p.110 / Chapter 5.2.6.1 --- Polyamide CC6 resin column chromatography --- p.111 / Chapter 5.2.6.2 --- Sephadex LH-20 gel column chromatography --- p.111 / Chapter 5.2.7 --- Antioxidant activity of commercially available tannin --- p.111 / Chapter 5.2.8 --- Bovine serum albumin precipitation --- p.112 / Chapter 5.2.9 --- Statistical analysis --- p.112 / Chapter 5.3 --- Results --- p.113 / Chapter 5.3.1 --- Effect of chemical/physical treatments on antioxidant activity of FR extract --- p.113 / Chapter 5.3.2 --- Effect of enzyme digestions on antioxidant activity of FR extract --- p.113 / Chapter 5.3.3 --- Chemical composition of FR extract --- p.118 / Chapter 5.3.4 --- Polyamide CC6 resin column chromatography --- p.118 / Chapter 5.3.5 --- Sephadex LH-20 gel column chromatography --- p.118 / Chapter 5.3.6 --- Antioxidant activity of commercially available tannin --- p.123 / Chapter 5.3.7 --- Effect of BSA precipitation on superoxide-scavenging activity --- p.123 / Chapter 5.4 --- Discussion --- p.127 / Conclusion --- p.131 / References --- p.132

by Lam Fung Chun. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (leaves 187-202). / Abstracts in English and Chinese. / Abstract --- p.i / Abstract in Chinese --- p.iii / Acknowledgements --- p.v / Table of Contents --- p.vi / List of Abbreviations --- p.xiii / List of Tables --- p.xvii / List of Figures --- p.xviii / Publication --- p.xx / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Epidemiology of Diabetes Mellitus --- p.1 / Chapter 1.2 --- Definition of Diabetes Mellitus --- p.1 / Chapter 1.3 --- Glucose Homeostasis and Diabetes Mellitus --- p.2 / Chapter 1.4 --- Classification of Diabetes Mellitus --- p.6 / Chapter 1.4.1 --- Type 1 Diabetes Mellitus --- p.6 / Chapter 1.4.2 --- Type 2 Diabetes Mellitus --- p.7 / Chapter 1.4.3 --- Gestational Diabetes Mellitus --- p.8 / Chapter 1.4.4 --- Other specific types --- p.8 / Chapter 1.5 --- Diagnostic Criteria of Diabetes Mellitus --- p.9 / Chapter 1.6 --- Complications of Diabetes Mellitus --- p.11 / Chapter 1.7 --- Pharmacological Treatment of Diabetes --- p.12 / Chapter 1.7.1 --- Treatment for type 1 diabetes mellitus --- p.12 / Chapter 1.7.2 --- Treatment for Type 2 diabetes mellitus --- p.13 / Chapter 1.7.2.1 --- Sulfonylureas --- p.14 / Chapter 1.7.1.2 --- Meglitinides --- p.15 / Chapter 1.7.1.3 --- Biguanides --- p.15 / Chapter 1.7.1.4 --- Thazolidinediones --- p.16 / Chapter 1.7.1.5 --- α-Glucosidase inhibitor --- p.16 / Chapter 1.8 --- Diabetes and Traditional Chinese Medicine --- p.17 / Chapter 1.9 --- Objective of this project --- p.18 / Chapter Chapter 2 --- "Botanical, Preparation and Authentication of Traditional Chinese Herbs" --- p.22 / Chapter 2.1 --- Introduction --- p.22 / Chapter 2.2 --- Herbal Materials --- p.22 / Chapter 2.3 --- Authentication of Herbal Material --- p.30 / Chapter 2.4 --- Extraction Method --- p.32 / Chapter 2.4.1 --- Material and Methods --- p.32 / Chapter 2.4.2 --- Results --- p.32 / Chapter 2.4 --- Discussion --- p.32 / Chapter Chapter 3 --- In vitro Studies on Selected Traditional Chinese Herbs --- p.35 / Chapter 3.1. --- Introduction --- p.35 / Chapter 3.2 --- Hepatic Gluconeogenesis Studies --- p.36 / Chapter 3.2.1 --- Introduction --- p.36 / Chapter 3.2.2 --- Material and Methods --- p.41 / Chapter 3.2.2.1 --- Cell Culture of H4IIE --- p.41 / Chapter 3.2.2.2 --- Glucose Production Assay --- p.42 / Chapter 3.2.2.3 --- Bicinchoninic Acid (BCA) Protein Assay --- p.43 / Chapter 3.2.3 --- Results --- p.44 / Chapter 3.3 --- Intestinal Glucose Absorption Studies --- p.46 / Chapter 3.3.1 --- Introduction --- p.46 / Chapter 3.3.2 --- Material and Methods --- p.48 / Chapter 3.3.2.1 --- Preparation of BBMV --- p.48 / Chapter 3.3.2.1.1 --- Chemicals --- p.48 / Chapter 3.3.2.1.2 --- Method --- p.48 / Chapter 3.3.2.2 --- Preparation of Herbal Extracts --- p.50 / Chapter 3.3.2.3 --- BBMV Glucose Uptake Assay --- p.51 / Chapter 3.3.2.4 --- Bicinchoninic Acid (BCA) Protein Assay --- p.54 / Chapter 3.3.3 --- Results --- p.54 / Chapter 3.4 --- Fibroblast Glucose Uptake Studies --- p.57 / Chapter 3.4.1 --- Introduction --- p.57 / Chapter 3.4.2 --- Material and Methods --- p.58 / Chapter 3.4.2.1 --- Cell Culture of Hs68 --- p.58 / Chapter 3.4.2.2 --- 2-Deoxy-D-glucose Uptake Assay --- p.59 / Chapter 3.4.2.3 --- Bicinchoninic Acid (BCA) Protein Assay --- p.60 / Chapter 3.4.3 --- Results --- p.60 / Chapter 3.5 --- Adipocyte Glucose Uptake Studies --- p.63 / Chapter 3.5.1 --- Introduction --- p.63 / Chapter 3.5.2 --- Material and Methods --- p.65 / Chapter 3.5.2.1 --- Cell Culture of 3T3-L1 --- p.65 / Chapter 3.5.2.2 --- Differentiation of 3T3-L1 --- p.65 / Chapter 3.5.2.3 --- 2-Deoxy-D-glucose Uptake Assay --- p.66 / Chapter 3.5.2.4 --- Bicinchoninic Acid (BCA) Protein Assay --- p.68 / Chapter 3.5.3 --- Results --- p.69 / Chapter 3.6 --- Glucose Transporter Type 4 (GLUT4) Expression Studies --- p.71 / Chapter 3.6.1 --- Introduction --- p.71 / Chapter 3.6.2 --- Material and Methods --- p.48 / Chapter 3.6.2.1 --- Cell Culture of 3T3-L1 --- p.71 / Chapter 3.6.2.2 --- Differentiation of 3T3-L1 --- p.71 / Chapter 3.6.2.3 --- GLUT4 Expression Assay --- p.72 / Chapter 3.6.2.4 --- Preparation of RNA --- p.72 / Chapter 3.6.2.5 --- RT-PCR --- p.73 / Chapter 3.6.2.6 --- PCR Analysis on GLUT4 Expression --- p.74 / Chapter 3.6.2.7 --- Real-time PCR --- p.75 / Chapter 3.6.3 --- Results --- p.77 / Chapter 3.7 --- Discussion --- p.81 / Chapter 3.7.1 --- Discussion of Hepatic Gluconeogenesis Studies --- p.81 / Chapter 3.7.2 --- Discussion of Intestinal Glucose Absorption Studies --- p.82 / Chapter 3.7.3 --- Discussion of Fibroblast Glucose Uptake Studies --- p.83 / Chapter 3.7.4 --- Discussion of Adipocyte Glucose Uptake Studies --- p.84 / Chapter 3.7.5 --- Discussion of Glucose Transporter Type 4 (GLUT4) Expression Studies --- p.86 / Chapter 3.7.6 --- Conclusion --- p.87 / Chapter Chapter 4 --- Purification of Cortex Moutan --- p.90 / Chapter 4.1 --- Introduction --- p.90 / Chapter 4.1.1 --- Phytochemical Studies of Cortex Moutan --- p.90 / Chapter 4.2 --- Organic Extraction of Cortex Moutan --- p.93 / Chapter 4.2.1 --- Extraction Material and Methods --- p.93 / Chapter 4.2.2. --- Results --- p.93 / Chapter 4.3 --- BBMV Glucose Uptake Assay with Cortex Moutan Organic Extract (CM-C and CM-D) --- p.96 / Chapter 4.3.1 --- Material and Methods --- p.48 / Chapter 4.3.2 --- Results --- p.96 / Chapter 4.4 --- Fractionation of CM-C and CM-D --- p.98 / Chapter 4.4.1 --- Material and Methods --- p.98 / Chapter 4.4.1.1 --- Chemicals --- p.98 / Chapter 4.4.1.2 --- Methods --- p.98 / Chapter 4.4.2 --- Results --- p.100 / Chapter 4.5 --- BBMV Glucose Uptake Assay of CM-C and CM-D Sub-fractions --- p.105 / Chapter 4.5.1 --- Results --- p.105 / Chapter 4.6 --- Sulfonylation of CM-D1 --- p.107 / Chapter 4.6.1 --- Material and Methods --- p.107 / Chapter 4.6.1.1 --- Chemicals --- p.107 / Chapter 4.6.1.2 --- Methods --- p.107 / Chapter 4.6.2 --- Structure Elucidation of CM-D1s --- p.108 / Chapter 4.6.2.1 --- 1H-NMR Analysis --- p.108 / Chapter 4.6.3 --- BBMV Glucose Uptake Assay of CM-D1s --- p.108 / Chapter 4.6.4 --- Results --- p.108 / Chapter 4.7 --- "Structural Elucidation of CM-D3, CM-D4 and CM-D5" --- p.112 / Chapter 4.7.1 --- Material and Methods --- p.112 / Chapter 4.7.1.1 --- Mass Spectrometry --- p.112 / Chapter 4.7.1.2 --- 1H-NMR Analysis --- p.112 / Chapter 4.7.2 --- Results --- p.113 / Chapter 4.8 --- "BBMV Glucose Uptake Assay of Acetovallione, CM-D3，CM-D4 and CM-D5" --- p.116 / Chapter 4.8.1 --- Results --- p.116 / Chapter 4.9 --- Synthesis of CM-D3s --- p.118 / Chapter 4.9.1 --- Material and Methods --- p.118 / Chapter 4.9.1.1 --- Chemicals --- p.118 / Chapter 4.9.1.2 --- Methods --- p.118 / Chapter 4.9.2 --- Structure Elucidation of synthesized product --- p.119 / Chapter 4.9.3 --- Results --- p.119 / Chapter 4.10 --- Discussion --- p.121 / Chapter Chapter 5 --- In vivo Studies on Selected Herbs --- p.123 / Chapter 5.1 --- Introduction --- p.123 / Chapter 5.1.1 --- Diabetic Animal Models --- p.123 / Chapter 5.1.2 --- Neonatal Streptozotocin-induced Diabetic Rat Model --- p.125 / Chapter 5.2 --- Oral Glucose Tolerance Test (OGTT) --- p.126 / Chapter 5.2.1 --- Animal --- p.126 / Chapter 5.2.2 --- Rat Induction Material and Methods --- p.126 / Chapter 5.2.3 --- Testing Method for diabetic condition of rats --- p.127 / Chapter 5.3.4 --- Results --- p.128 / Chapter 5.3 --- Basal Glycaemia Test --- p.138 / Chapter 5.3.1 --- Animal --- p.138 / Chapter 5.3.2 --- Rat Induction Material and Methods --- p.138 / Chapter 5.3.3 --- Testing Method --- p.138 / Chapter 5.3.4 --- Results --- p.140 / Chapter 5.4 --- Discussion --- p.143 / Chapter Chapter 6 --- General Discussion --- p.147 / Chapter 6.1 --- Introduction --- p.147 / Chapter 6.2 --- Summary of Research Findings --- p.151 / Chapter 6.3 --- Result Interpretation --- p.152 / Chapter 6.3.1 --- Result Interpretation of In Vitro Studies --- p.152 / Chapter 6.3.2 --- Result Interpretation of Cortex Moutan Purification --- p.154 / Chapter 6.3.3 --- Result Interpretation of In Vivo Studies --- p.157 / Chapter 6.4 --- Limitations and Improvements --- p.161 / Chapter 6.5 --- Future Directions --- p.163 / Chapter 6.6 --- Conclusions --- p.169 / Appendices --- p.170 / References --- p.187

Law Ka Yee. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2006. / Includes bibliographical references (leaves 214-225). / Abstracts in English and Chinese. / ACKNOWLEDGEMENTS --- p.I / ABSTRACT --- p.II / TABLE OF CONTENTS --- p.VII / LIST OF FIGURES --- p.X / LIST OF TABLES A --- p.XII / APPENDIX --- p.XIII / Chapter CHAPTER ONE --- LITERATURE REVIEW --- p.1 / Chapter 1.1 --- Chinese herbs --- p.1 / Chapter 1.1.1 --- Introduction --- p.1 / Chapter 1.1.2 --- Leigongteng --- p.2 / Chapter 1.1.2.1 --- Leigongteng and its importance --- p.2 / Chapter 1.1.2.2 --- Chemical components and pharmacological effects of Leigongteng --- p.4 / Chapter 1.1.3 --- Problems in authentication of Leigongteng --- p.5 / Chapter 1.1.3.1 --- Taxonomic problems of Tripterygium --- p.5 / Chapter 1.1.3.2 --- Confusion caused by other species --- p.7 / Chapter 1.1..3.3 --- Adulterants --- p.9 / Chapter 1.2 --- Celastraceae --- p.10 / Chapter 1.2.1 --- Introduction --- p.10 / Chapter 1.2.2 --- Controversial taxonomic issue --- p.12 / Chapter 1.2.1.1 --- Subfamilies of Celastraceae --- p.12 / Chapter 1.2.1.2 --- Subfamily Tripterygioideae --- p.13 / Chapter 1.3 --- Molecular authentication --- p.14 / Chapter 1.4 --- Molecular systematics --- p.18 / Chapter 1.4.1 --- DNA sequence markers --- p.19 / Chapter 1.4.2 --- Molecular phylogeny --- p.25 / Chapter 1.4.2.1 --- Tree-building method --- p.25 / Chapter 1.4.2.2. --- Measures of support --- p.28 / Chapter 1.5 --- Objectives --- p.29 / Chapter CHAPTER TWO --- MATERIALS AND METHODS --- p.31 / Chapter 2.1 --- Plant and herb samples --- p.31 / Chapter 2.2 --- DNA extraction --- p.41 / Chapter 2.2.1 --- Modified CTAB extraction --- p.41 / Chapter 2.2.2 --- Commercial kit extraction --- p.42 / Chapter 2.3 --- Polymerase chain reaction (PCR) condition --- p.43 / Chapter 2.4 --- DNA gel electrophoresis --- p.44 / Chapter 2.5 --- PCR product purification --- p.45 / Chapter 2.5.1 --- GEL-M´ёØ gel extraction system --- p.45 / Chapter 2.6 --- Ligation and transformation --- p.46 / Chapter 2.6.1 --- Ligation and transformation --- p.46 / Chapter 2.6.2 --- Cell cultivation --- p.47 / Chapter 2.6.3 --- Plasmid extraction --- p.47 / Chapter 2.7 --- Determination of DNA concentration --- p.49 / Chapter 2.8 --- Cycle sequencing --- p.49 / Chapter 2.9 --- Sequence analysis --- p.50 / Chapter 2.10 --- Materials preparation --- p.51 / Chapter CHAPTER THREE --- MOLECULAR AUTHENTICATION OF LEIGONGTENG --- p.54 / Chapter 3.1. --- Authentication based on internal transcribed spacer (ITS) region --- p.54 / Chapter 3.1.1 --- Sequence alignment --- p.54 / Chapter 3.1.2 --- ITS region nucleotide differences significant in authentication of Leigongteng --- p.55 / Chapter 3.1.3 --- Relationship of samples --- p.70 / Chapter 3.1.4 --- Comparison of sequences --- p.75 / Chapter 3.2 --- Authentication based on 5s-rDNA region --- p.78 / Chapter 3.2.1 --- Sequence alignment --- p.78 / Chapter 3.2.2 --- 5s-rDNA nucleotide differences significant in authentication of Leigongteng --- p.78 / Chapter 3.2.3 --- Relationship of samples --- p.88 / Chapter 3.2.4 --- Comparison of sequences --- p.90 / Chapter 3.3 --- Authentication based on psbA-trnH region --- p.93 / Chapter 3.3.1 --- Sequence alignment --- p.93 / Chapter 3.3.2 --- psbA-trnH nucleotide differences significant in authentication of Leigongteng --- p.101 / Chapter 3.3.3 --- Relationship of samples --- p.113 / Chapter 3.3.4 --- Comparison of sequences --- p.115 / Chapter 3.4 --- Authentication based on trnL-F region --- p.118 / Chapter 3.4.1 --- Sequence alignment --- p.118 / Chapter 3.4.2 --- trnL-F region nucleotide differences significant in authentication of Leigongteng --- p.121 / Chapter 3.4.3 --- Relationship of samples --- p.139 / Chapter 3.4.4 --- Comparison of sequences --- p.141 / Chapter 3.5 --- Discussion --- p.144 / Chapter 3.5.1 --- Molecular markers --- p.144 / Chapter CHAPTER FOUR --- PHYLOGENETIC STUDIES ON TRIPTERYGIUM --- p.151 / Chapter 4.1 --- Combine loci of ITS and 5s-rDNA regions --- p.152 / Chapter 4.1.1 --- Homogenity test --- p.152 / Chapter 4.1.2 --- Sequence alignment --- p.152 / Chapter 4.1.3 --- Phylogenetic study --- p.173 / Chapter 4.2 --- psbA-trnH region --- p.174 / Chapter 4.2.1 --- Sequence alignment --- p.174 / Chapter 4.3 --- Discussion --- p.177 / Chapter CHAPTER FIVE --- PHYLOGENETIC STUDIES ON TRIPTERYGIOIDEAE AND CELASTRACEAE --- p.191 / Chapter 5.1 --- ITS regions --- p.191 / Chapter 5.1.1 --- Sequence alignment --- p.191 / Chapter 5.1.2 --- Phylogenetic analysis --- p.205 / Chapter 5.2 --- Discussion --- p.206 / Chapter 5.2.1 --- Subfamily Tripterygioideae --- p.206 / Chapter 5.2.2 --- Subfamilies of Celastraceae --- p.210 / Chapter CHAPTER SIX --- CONCLUSION --- p.212 / BILBIOGRAPHY --- p.214

Background. Danshen, the dried root of Salvia miltiorrhiza Bge, is used for treating coronary heart disease. In China, numerous pharmaceutical dosage forms of Danshen are commercially available. Although the pharmacological effects of different components of Danshen are well identified, its absorption as well as pharmacokinetics studies are still insufficient and inconsistent. The current study aims to: (1) screen for the major absorbable active components of Danshen; (2) interpret the absorption mechanism and pharmacokinetics characteristics of the identified components; (3) develop an improved oral drug delivery system for the identified components of Danshen. / Conclusion. Both danshensu and SAB have limited intestinal permeability and oral bioavailabilities. Our results demonstrated the usefulness of sodium caprate as a potential absorption enhancer for danshensu and SAB in Danshen product. / Methods. Six major active components in commercially available Danshen products were identified and quantified. In vitro human Caco-2 cell monolayer model, rat in situ intestinal perfusion model as well as rat in vivo pharmacokinetic model were used to investigate the intestinal absorption and pharmacokinetics profiles of the identified Danshen components. Effect of the absorption enhancer on the oral absorption and bioavailabilities of the studied Danshen components was further evaluated. / Results. Danshensu, salvianolic acid B (SAB) and protocatechuic aldehyde (PCA) were identified as the major components in Danshen products. Investigations using in vitro, in situ and in vivo model found that both danshensu and SAB had poor permeabilities and low bioavailabilities (Danshensu: 11.09%; SAB: 3.90%), which may be due to their absorption via the paracellular transport pathways. Studies of PCA suggested that it may have a intestinal first pass metabolism with an oral bioavailability of only 18.02%. It was found that the permeabilities of both danshensu and SAB were significantly increased upon addition of sodium caprate, a paracellular absorption enhancer. The oral bioavailabilities of both danshensu and SAB in pure compound form as well as Danshen extract form were also increased in the presence of sodium caprate in rats. / Zhou, Limin. / Advisers: Zuo Zhong; Moses S.S. Chow. / Source: Dissertation Abstracts International, Volume: 70-06, Section: B, page: 3457. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references. / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.

Basing on the traditional TCM interpretation, experience of recent research studies and our experimental findings, a few component herbs in Formulae 1 & 2 would be tentatively selected for a new formula. They were Radix Rehmanniae, Radix Astragali, Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis, Cortex Moutan and Rhizoma Smilacis Chinensis. Whether the new formula could give better efficacy would need to be tested in new clinical trials and experimental models. (Abstract shortened by UMI.) / Diabetes mellitus has long been a clinical problem for hundreds of years. More than 194 million people in the world now suffer from the disorder. About 15% of all diabetic patients would develop unhealing foot ulcers which compile significant proportion of nontraumatic lower-extremity amputations. Basing on the clinical experience of Prof. Xi Jiu Yi in Shanghai, literature review and an innovative interpretation of traditional Chinese medicine, two formulae (F1 & F2) derived from a well known herbal formula: the "Pills of Six Drugs with Rehmannia" were created for clinical trials. With the early successful limb salvage rate of over 80% observed in a clinical series studied at the Prince of Wales Hospital, Hong Kong, multi-directional studies on the two formulae were carried out. The aim was to find out the clinical efficacy of Formulae 1 & 2, and their component herbs, and the biological mechanism of action. A series of in-vitro, ex-vivo and in-vivo experimental models were completed for the latter purposes. / Granulation formation is an important issue essential for ulcer healing. Therefore a CRL-7522 fibroblast cell line and primary fibrobass from eight diabetic foot ulcer patients (ex-vivo) were used to detect the granulation enhancing activities of the Formulae 1 & 2 and component herbs. The two formulae and some of their component herbs viz, Radix Astragali (HQ), Radix Rehmanniae (SD) and Rhizoma Atractylodis Macrocephalae (BZ) showed significant enhancement effects on the cell viability and apparently facilitated granulation formation. Hence the Formulae 1 & 2, and the three component herbs were selected for further studies. The other nine component herbs of the formulae were found to have no significant enhancing effects on cell viability. With an established diabetic rat model (n0 STZ and n5 STZ), a piece of full-thickness skin was removed from the foot of the rat to develop a diabetic rat foot ulcer model. The ulcer area was measured by a specially designed area measuring programme, namely the Image Analytical Programme. The ulcer areas and their percentage reductions over time were recorded and analysed using statistical multilevel models with adjustments for weight, blood glucose level and the presence of extra ulcers. Results revealed that the ulcer area was significantly reduced by the Formulae 1 & 2, and one of their component herbs, Radix Rehmanniae (SD). / Lau Tai-Wai. / "February 2005." / Adviser: Ping Chung Leung. / Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0197. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (p. 292-310). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.

Wang, Xiaoan. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 145-166). / Abstracts in English and Chinese. / Table of Contents --- p.I / Acknowledgements --- p.VI / Publications --- p.VII / Abstract (in English) --- p.VIII / Abstract (in Chinese) --- p.X / List of Figures --- p.XII / List of Tables --- p.XVI / List of Abbreviations --- p.XVII / Chapter Chapter One. --- Introduction --- p.1 / Chapter 1.1 --- Overview of oseltamivir --- p.1 / Chapter 1.1.1 --- General description of oseltamivir --- p.1 / Chapter 1.1.2 --- Pharmacological activities of oseltamivir --- p.3 / Chapter 1.1.3 --- Pharmacokinetics of oseltamivir --- p.3 / Chapter 1.1.3.1 --- Absorption of oseltamivir --- p.4 / Chapter 1.1.3.2 --- Distribution of oseltamivir --- p.5 / Chapter 1.1.3.3 --- Metabolism of oseltamivir --- p.6 / Chapter 1.1.3.4 --- Elimination of oseltamivir --- p.8 / Chapter 1.1.4 --- Side effects and toxicities of oseltamivir --- p.9 / Chapter 1.2 --- Overview of Chinese medicine formulae CMF1 (Yinqiaosan and Sangjuyin) --- p.9 / Chapter 1.2.1 --- Background and clinical use of CMF1 --- p.9 / Chapter 1.2.2 --- Quality control of CMF1 by manufacturer --- p.11 / Chapter 1.2.3 --- Major active components of CMF1 --- p.12 / Chapter 1.3 --- Previous studies on herb-drug interactions between O and CMF1 --- p.18 / Chapter 1.4 --- Rationale of the current study --- p.19 / Chapter 1.5 --- objectives --- p.19 / Chapter Chapter Two. --- Identification and quantification of major marker compounds in Yinqiaosan and Sangiuyin products --- p.20 / Chapter 2.1 --- Introduction --- p.20 / Chapter 2.2 --- Materials and methods --- p.23 / Chapter 2.2.1 --- Chemicals --- p.23 / Chapter 2.2.2 --- Instruments --- p.24 / Chapter 2.2.3 --- Chromatographic conditions --- p.24 / Chapter 2.2.4 --- Preparation of standard solutions --- p.25 / Chapter 2.2.5 --- Calibration curves --- p.26 / Chapter 2.2.6 --- Validation of the assay method --- p.26 / Chapter 2.2.7 --- Sample preparations for Yinqiaosan and Sangjuyin products --- p.27 / Chapter 2.2.7.1 --- Sample extraction from Yinqiaosan or Sangjuyin granules --- p.27 / Chapter 2.2.7.2 --- Sample extraction from Yinqiaosan or Sangjuyin tablets --- p.27 / Chapter 2.2.7.3 --- Sample extraction recoveries --- p.27 / Chapter 2.3 --- Results and discussions --- p.28 / Chapter 2.3.1 --- Chromatography --- p.28 / Chapter 2.3.2 --- Linearity and sensitivity --- p.33 / Chapter 2.3.3 --- Accuracy and precision --- p.33 / Chapter 2.3.4 --- Stability --- p.36 / Chapter 2.3.5 --- Contents of identified active components in commercial available Yinqiaosan or Sangjuyin products and CMF1 --- p.36 / Chapter 2.3.6 --- Sample extraction recovery --- p.40 / Chapter 2.4 --- Conclusion --- p.43 / Chapter Chapter Three. --- Effect of CMF1/CMF1 components on the metabolism of oseltamivir and related mechanistic studies --- p.44 / Chapter 3.1 --- Introduction --- p.44 / Chapter 3.2 --- Materials and methods --- p.47 / Chapter 3.2.1 --- Materials --- p.47 / Chapter 3.2.2 --- "Verification of metabolism of O in rat GI tract, plasma and liver microsome" --- p.48 / Chapter 3.2.3 --- Inhibition of metabolism of O by CMFl/CMFl components --- p.49 / Chapter 3.2.3.1 --- In vitro inhibition of metabolism of O in rat plasma --- p.49 / Chapter 3.2.3.2 --- In vitro inhibition of metabolism of O in rat liver microsome (RLM) --- p.49 / Chapter 3.2.4 --- Mechanistic study of enzyme inhibition of O in recombinant human Carboxylesterase 1 (hCE 1) --- p.50 / Chapter 3.2.5 --- Sample preparation and LC/MS/MS analysis --- p.50 / Chapter 3.2.6 --- Data analyses --- p.52 / Chapter 3.3 --- Results --- p.53 / Chapter 3.3.1 --- "Verification of metabolism of O in rat GI tract, plasma and liver microsome" --- p.53 / Chapter 3.3.2 --- Inhibition of metabolism of O by CMF1/CMF1 components --- p.53 / Chapter 3.3.2.1 --- Enzyme inhibition of metabolism of O by CMFl/CMF1 components in rat plasma --- p.53 / Chapter 3.3.2.2 --- Enzyme inhibition of metabolism of O by CMF1/CMF1 components in rat liver microsome (RLM) --- p.58 / Chapter 3.3.2.3 --- Selection of potent enzyme inhibitor from CMF1 --- p.60 / Chapter 3.3.4. --- Mechanistic study of enzyme inhibition of O in recombinant human Carboxylesterase 1 (hCE 1) --- p.61 / Chapter 3.4 --- Discussions --- p.63 / Chapter 3.5 --- Conclusion --- p.74 / Chapter Chapter Four. --- Effect of CMFl/CMFl components on the absorption of oseltamivir and related mechanistic studies --- p.75 / Chapter 4.1 --- Introduction --- p.75 / Chapter 4.2 --- Materials and methods --- p.79 / Chapter 4.2.1 --- Materials --- p.79 / Chapter 4.2.2 --- PAMPA permeation model --- p.80 / Chapter 4.2.2.1 --- Permeation of O and OC in PAMPA --- p.80 / Chapter 4.2.2.2 --- Sample preparation and LC/MS/MS analysis --- p.81 / Chapter 4.2.2.3 --- Data analysis --- p.81 / Chapter 4.2.3 --- Absorption of O in presence of CMF/CMFl components in Caco-2 and MDCK cell monolayer models --- p.82 / Chapter 4.2.3.1 --- Cell culture --- p.82 / Chapter 4.2.3.2 --- Preparation of loading solutions to the cell models --- p.83 / Chapter 4.2.3.3 --- Stability of O in transport buffer --- p.84 / Chapter 4.2.3.4 --- Cytotoxicity tests of O and CMFl/CMFl components --- p.84 / Chapter 4.2.3.5 --- Transport study in Caco-2 and MDCK monolayer model --- p.85 / Chapter 4.2.3.6 --- Sample preparation and LC/MS/MS analysis --- p.86 / Chapter 4.2.3.7 --- Data analysis --- p.87 / Chapter 4.2.4 --- Absorption of O in presence of CMF 1 in rat in situ single pass intestinal perfusion model --- p.88 / Chapter 4.2.4.1 --- Preparation of perfusion solutions --- p.88 / Chapter 4.2.4.2 --- Stabilities of O and arctigenin in perfusate --- p.88 / Chapter 4.2.4.3 --- Rat in situ single pass intestinal perfusion of O in presence and absence of CMFl and relevant inhibitors --- p.89 / Chapter 4.2.4.4 --- Sample preparation and LC/MS/MS analysis --- p.90 / Chapter 4.2.4.5 --- Data analysis --- p.90 / Chapter 4.3 --- Resul ts --- p.91 / Chapter 4.3.1 --- Permeation of O and OC in PAMPA --- p.91 / Chapter 4.3.2 --- Absorption of O in presence of CMF/CMF1 components in Caco-2 and MDCK cell monolayer models --- p.92 / Chapter 4.3.2.1 --- Stabilities of O in transport buffer --- p.92 / Chapter 4.3.2.2 --- Cytotoxicity tests of O and CMF1/CMF1 components in transport buffer --- p.93 / Chapter 4.3.2.3 --- Proof of O as a substrate of P-gp by Caco-2 cell model --- p.95 / Chapter 4.3.2.4 --- Effect of CMF 1 on the absorption transport of o in Caco-2 cell mode --- p.98 / Chapter 4.3.2.5 --- Effect of CMF1 components on the absorption transport of o in Caco-2 cell model --- p.102 / Chapter 4.3.2.6 --- Effect of arctigenin on bi-directional transport of o in Caco- 2 cell model --- p.106 / Chapter 4.3.2.7 --- Proof of O as a substrate of P-gp by MDCK transfected cell lines --- p.108 / Chapter 4.3.2.8 --- Bi-directional transport of O in MDCK-MDR1 cell model --- p.111 / Chapter 4.3.2.9 --- Effect of CMF 1 on the absorption transport of O in MDCK-MDR1 cell model --- p.112 / Chapter 4.3.3 --- Absorption of O in presence of CMF1 in rat in situ single pass intestinal perfusion model --- p.113 / Chapter 4.3.3.1 --- Stabilities of O and arctigenin in the perfusion buffer --- p.113 / Chapter 4.3.3.2 --- Intestinal absorption of O in presence and absence of CMF1 in rat in situ intestinal perfusion model --- p.114 / Chapter 4.4 --- Discussions --- p.116 / Chapter 4.5 --- Conclusion --- p.124 / Chapter Chapter Five. --- Preliminary evaluation of antiviral activity of CMFl/CMFl components --- p.125 / Chapter 5.1 --- Introduction --- p.125 / Chapter 5.2 --- Materials and methods --- p.128 / Chapter 5.2.1 --- Materials and animals --- p.128 / Chapter 5.2.2 --- Animal treatment --- p.129 / Chapter 5.2.3 --- Plasma sample collection and preparation --- p.130 / Chapter 5.2.4 --- Evaluation of antiviral activities of CMFl/ CMFl components --- p.130 / Chapter 5.2.4.1 --- Plaque reduction assay --- p.131 / Chapter 5.2.4.2 --- Optimization of plasma sample dilution ratio --- p.131 / Chapter 5.2.5 --- Data analyses --- p.133 / Chapter 5.3 --- Results and discussions --- p.135 / Chapter 5.3.1 --- Ex vivo evaluation of antiviral activity of CMF1 --- p.135 / Chapter 5.3.2 --- In vitro evaluation of antiviral activity of CMF1 major marker compounds --- p.139 / Chapter 5.4 --- Conclusion --- p.141 / Chapter Chapter Six. --- Overall conclusion --- p.142 / References --- p.145